Neogen (NEOG) CEO Reports Stock and Option Grants at $5.43

Rhea-AI Filing Summary

Nassif Mikheal, identified as CEO and a director of Neogen Corp (NEOG), reported multiple acquisitions on 08/15/2025. He acquired 184,162 shares of common stock and 414,365 shares of common stock at $5.43 per share, leaving 598,527 shares beneficially owned after the transactions. He also acquired derivative rights (options/RSU/PSU grants) exercisable into 1,065,042 and 473,352 shares with an exercise/conversion price of $5.43 and expiration/vesting noted as 08/15/2035. The filing includes vesting schedule notes: some options/RSUs vest over three years, others over four years, and PSUs vest in total at the three-year anniversary. The Form 4 was signed by an attorney-in-fact on 08/19/2025.

Positive

• Significant insider acquisition: CEO reported acquiring a total of 598,527 common shares, indicating increased insider ownership.
• Clearly disclosed vesting terms: The filing specifies vesting schedules for options, RSUs, and PSUs, providing transparency on future dilution timing.

Negative

• No material negatives disclosed in the Form 4; the filing records acquisitions and vesting schedules without adverse events.

Insights

Financial Analyst

TL;DR: CEO Nassif Mikheal reported sizable stock and derivative acquisitions at $5.43, increasing his beneficial ownership to 598,527 shares.

The transactions show the CEO received both immediate non-derivative shares and long-dated derivative awards tied to $5.43 strike/conversion price with 2035 dates or multi-year vesting. The mix of vested equity and time‑based awards indicates compensation or planned grants rather than market purchases. The amounts are material on an absolute basis for insider holdings disclosure and are clearly documented in the Form 4.

Corporate Governance Expert

TL;DR: Filing documents standard insider award vesting schedules and required Section 16 disclosure, executed by attorney-in-fact.

The Form 4 provides required disclosure of acquisitions and vesting terms, including specific counts, exercise prices, and vesting cadence. The signature by an attorney-in-fact on 08/19/2025 fulfills procedural requirements. No additional governance concerns or departures from typical grant disclosure are evident in the provided text.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Nassif Mikheal

(Last) (First) (Middle)

620 LESHER PLACE

(Street)

LANSING MI 48912

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
NEOGEN CORP [ NEOG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CEO

3. Date of Earliest Transaction (Month/Day/Year)
08/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/15/2025		A		184,162(3)	A	$5.43	184,162	D
Common Stock	08/15/2025		A		414,365(2)	A	$5.43	598,527	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Common Stock (Right to Buy)	$5.43	08/15/2025		A		1,065,042		(1)	08/15/2035	Common Stock	1,065,042	$0	1,065,042	D
Common Stock (Right to Buy)	$5.43	08/15/2025		A		473,352		(3)	08/15/2035	Common Stock	473,352	$0	473,352	D

Explanation of Responses:

1. Options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants

2. PSUs vest in total at the end of the three year anniversary date of the grant

3. Options and RSUs vest in equal annual installments on each of the first four anniversary dates of the grants

	Christopher Sefcheck (Attorney in Fact)	08/19/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What shares did Nassif Mikheal acquire according to the NEOG Form 4?

The filing reports acquisitions of 184,162 and 414,365 shares of Neogen common stock at $5.43 per share.

How many Neogen shares does Nassif Mikheal beneficially own after the reported transactions?

The Form 4 shows 598,527 shares beneficially owned following the reported transactions.

What derivative securities were reported in the Form 4 for NEOG?

Derivatives reported include rights to buy 1,065,042 and 473,352 shares with a $5.43 exercise/conversion price and referenced 08/15/2035 dates.

When were the transactions in the NEOG Form 4 executed and when was the form signed?

Transactions are dated 08/15/2025 and the Form 4 was signed by an attorney-in-fact on 08/19/2025.

What are the vesting arrangements disclosed in the Form 4?

Notes state options and RSUs vest in equal annual installments over three or four years depending on the grant, and PSUs vest in total at the three-year anniversary.